CLSI C37-A (R2018)

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of January 2019. Because of its value to the laboratory community, it is being retained in CLSI's library.

This guideline details procedures for the manufacture and evaluation of human serum pools for cholesterol measurement.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.